Gertz, M. A., Landau, H., Comenzo, R. L., Seldin, D., Weiss, B., Zonder, J., . . . Liedtke, M. (2016). First-in-human phase I/II study of NEOD001 in patients with light chain amyloidosis and persistent organ dysfunction. Journal of clinical oncology, 34(10), .
Chicago-Zitierstil (17. Ausg.)Gertz, Morie A., et al. "First-in-human Phase I/II Study of NEOD001 in Patients with Light Chain Amyloidosis and Persistent Organ Dysfunction." Journal of Clinical Oncology 34, no. 10 (2016).
MLA-Zitierstil (9. Ausg.)Gertz, Morie A., et al. "First-in-human Phase I/II Study of NEOD001 in Patients with Light Chain Amyloidosis and Persistent Organ Dysfunction." Journal of Clinical Oncology, vol. 34, no. 10, 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.